Hadengue A - Search Results

1

Hadengue A, Negro F. Hadengue A, et al. Rev Med Suisse. 2007 Sep 5;3(123):1931. Rev Med Suisse. 2007. PMID: 17918486 French. No abstract available.

2

Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.

Giostra E, Kullak-Ublick GA, Keller W, Fried R, Vanlemmens C, Kraehenbuhl S, Locher S, Egger HP, Clavien PA, Hadengue A, Mentha G, Morel P, Negro F. Giostra E, et al. Among authors: hadengue a. Transpl Int. 2004 May;17(4):169-76. doi: 10.1007/s00147-004-0695-6. Epub 2004 Apr 2. Transpl Int. 2004. PMID: 15060764 Free article. Clinical Trial.

3

Immunological and virological effects of ribavirin in hepatitis C after liver transplantation.

Quadri R, Giostra E, Roskams T, Pawlotsky JM, Mentha G, Rubbia-Brandt L, Perrin L, Hadengue A, Negro F. Quadri R, et al. Among authors: hadengue a. Transplantation. 2002 Feb 15;73(3):373-8. doi: 10.1097/00007890-200202150-00010. Transplantation. 2002. PMID: 11884933

4

Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C.

Broers B, Helbling B, François A, Schmid P, Chuard C, Hadengue A, Negro F; Swiss Association for the Study of the Liver (SASL 18). Broers B, et al. Among authors: hadengue a. J Hepatol. 2005 Mar;42(3):323-8. doi: 10.1016/j.jhep.2004.11.018. J Hepatol. 2005. PMID: 15791696 Clinical Trial.

5

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.

Bibert S, Roger T, Calandra T, Bochud M, Cerny A, Semmo N, Duong FH, Gerlach T, Malinverni R, Moradpour D, Negro F, Müllhaupt B, Bochud PY; Swiss Hepatitis C Cohort Study. Bibert S, et al. J Exp Med. 2013 Jun 3;210(6):1109-16. doi: 10.1084/jem.20130012. Epub 2013 May 27. J Exp Med. 2013. PMID: 23712427 Free PMC article.

6

Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development.

Lange CM, Miki D, Ochi H, Nischalke HD, Bojunga J, Bibert S, Morikawa K, Gouttenoire J, Cerny A, Dufour JF, Gorgievski-Hrisoho M, Heim MH, Malinverni R, Müllhaupt B, Negro F, Semela D, Kutalik Z, Müller T, Spengler U, Berg T, Chayama K, Moradpour D, Bochud PY; Hiroshima Liver Study Group; Swiss Hepatitis C Cohort Study Group. Lange CM, et al. PLoS One. 2013 May 29;8(5):e64053. doi: 10.1371/journal.pone.0064053. Print 2013. PLoS One. 2013. PMID: 23734184 Free PMC article.

7

[Management of liver cirrhosis: how far is not too far?].

Abetel G, Danthe C, Hungerbohler P, Lavanchy JD, Nicollier A, Russ D, Hadengue A, Vannotti M. Abetel G, et al. Among authors: hadengue a. Rev Med Suisse. 2006 Nov 8;2(86):2561-6, 2568-71. Rev Med Suisse. 2006. PMID: 17168046 French. No abstract available.

8

[Alcoholic liver disease: another neglected disease?].

Hadengue A, Moradpour D. Hadengue A, et al. Rev Med Suisse. 2012 Sep 5;8(352):1643-4. Rev Med Suisse. 2012. PMID: 22988722 French. No abstract available.

9

[Liver disease in obese patients].

Giostra E, Huber O, Morel P, Hadengue A. Giostra E, et al. Among authors: hadengue a. Rev Med Suisse. 2007 Sep 5;3(123):1939-41. Rev Med Suisse. 2007. PMID: 17918488 Review. French.

10

[Immunization guidelines in patients with chronic liver diseases].

Bihl F, Hadengue A, Siegrist CA. Bihl F, et al. Among authors: hadengue a. Rev Med Suisse. 2007 Sep 5;3(123):1948, 1950-1. Rev Med Suisse. 2007. PMID: 17918490 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters